Prediction of Human Volume of Distribution Using in vivo, in vitro, and in silico Approaches

被引:9
作者
Obach, R. Scott [1 ]
机构
[1] Pfizer Global Res & Dev, Dept Pharmacokinet Pharmacodynam & Drug Metab, Groton Labs, Groton, CT USA
来源
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 42 | 2007年 / 42卷
关键词
D O I
10.1016/S0065-7743(07)42030-9
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
[No abstract available]
引用
收藏
页码:469 / 488
页数:20
相关论文
共 41 条
[1]   BINDING OF BASIC AND ACIDIC DRUGS TO RAT TISSUE SUBCELLULAR-FRACTIONS [J].
BICKEL, MH ;
STEELE, JW .
CHEMICO-BIOLOGICAL INTERACTIONS, 1974, 8 (03) :151-162
[2]   Prediction of the volume of distribution of a drug:: which tissue-plasma partition coefficients are needed? [J].
Björkman, S .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2002, 54 (09) :1237-1245
[3]   Allometric scaling of pharmacokinetic parameters in drug discovery:: Can human CL, VSS and t1/2 be predicted from in-vivo rat data? [J].
Caldwell, GW ;
Masucci, JA ;
Yan, ZY ;
Hageman, W .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2004, 29 (02) :133-143
[4]   PREDICTION OF DRUG DISTRIBUTION IN DISTRIBUTION DIALYSIS AND INVIVO FROM BINDING TO TISSUES AND BLOOD [J].
CLAUSEN, J ;
BICKEL, MH .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1993, 82 (04) :345-349
[5]   MEMBRANE LIPIDS AS INTRACELLULAR BINDERS OF CHLORPROMAZINE AND RELATED DRUGS [J].
DIFRANCESCO, C ;
BICKEL, MH .
CHEMICO-BIOLOGICAL INTERACTIONS, 1977, 16 (03) :335-346
[6]  
FICHTL B, 1980, J PHARMACOL EXP THER, V215, P248
[7]   Quantitative structure-pharmacokinetic relationship modelling: apparent volume of distribution [J].
Ghafourian, T ;
Barzegar-Jalali, M ;
Hakimiha, N ;
Cronin, MTD .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2004, 56 (03) :339-350
[8]   QSPR models for the prediction of apparent volume of distribution [J].
Ghafourian, Taravat ;
Barzegar-Jalali, Mohammad ;
Dastmalchi, Siavoush ;
Khavari-Khorasani, Tina ;
Hakimiha, Nasim ;
Nokhodchi, Ali .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 319 (1-2) :82-97
[9]   In silico human and rat Vss quantitative structure-activity relationship models [J].
Gleeson, MP ;
Waters, NJ ;
Paine, SW ;
Davis, AM .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (06) :1953-1963
[10]  
HINDERLING PH, 1988, PROG PHARMACOL, V6, P1